To confirm this, we treated HUVECs with the proteasome inhibitor MG132 and the protein synthesis inhibitor cycloheximide (CHX, 10 g/mL)
Traditionally, options were limited to painkillers, steroids, or surgery
Complementary work has documented activation of the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) pathway, involved in angiogenesis, along with upregulation of early growth response genes (Egr-1) and the FAK-paxillin transcription factor in studied endothelial cells
Testing: Third-party lab report available where provided
Singh V, Sharma AK, Narasimhan RL, Bhalla A, Sharma N, Sharma R (2014) Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study